{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T07:47:33Z","timestamp":1774424853968,"version":"3.50.1"},"reference-count":161,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100010892","name":"Department of Science and Technology, Republic of the Philippines","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006733","name":"Commission on Higher Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006733","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BioDrugs"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s40259-025-00764-8","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T07:13:44Z","timestamp":1770966824000},"page":"279-300","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Web of Potentials: Neuroactive Components of Spider Venom and Their Emerging Pharmacologic Applications in Neurologic Diseases"],"prefix":"10.1007","volume":"40","author":[{"given":"Joshua Lawrence C.","family":"Bautista","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elian Angelo M.","family":"Abellanosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaden G.","family":"Jardiolin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rizelle Anne A.","family":"Calpo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles Nylxon C.","family":"Noriega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark Kevin P.","family":"Devanadera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon Miguel M.","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2031-0300","authenticated-orcid":false,"suffix":"Jr.","given":"Leonardo A.","family":"Guevarra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,13]]},"reference":[{"issue":"1","key":"764_CR1","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/brv.12793","volume":"97","author":"T L\u00fcddecke","year":"2022","unstructured":"L\u00fcddecke T, Herzig V, von Reumont BM, Vilcinskas A. The biology and evolution of spider venoms. Biol Rev Camb Philos Soc. 2022;97(1):163\u201378. https:\/\/doi.org\/10.1111\/brv.12793.","journal-title":"Biol Rev Camb Philos Soc"},{"issue":"10","key":"764_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/toxins11100611","volume":"11","author":"N Langenegger","year":"2019","unstructured":"Langenegger N, Nentwig W, Kuhn-Nentwig L. Spider venom: components, modes of action, and novel strategies in transcriptomic and proteomic analyses. Toxins. 2019;11(10):611. https:\/\/doi.org\/10.3390\/toxins11100611.","journal-title":"Toxins"},{"key":"764_CR3","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.toxicon.2018.11.298","volume":"158","author":"NJ Saez","year":"2019","unstructured":"Saez NJ, Herzig V. Versatile spider venom peptides and their medical and agricultural applications. Toxicon. 2019;158:109\u201326. https:\/\/doi.org\/10.1016\/j.toxicon.2018.11.298.","journal-title":"Toxicon"},{"issue":"5","key":"764_CR4","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/S1474-4422(19)30029-8","volume":"18","author":"WM Caroll","year":"2019","unstructured":"Caroll WM. The global burden of neurological disorders. Lancet Neurol. 2019;18(5):418\u20139. https:\/\/doi.org\/10.1016\/S1474-4422(19)30029-8.","journal-title":"Lancet Neurol"},{"key":"764_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.950457","volume":"13","author":"A Rauf","year":"2022","unstructured":"Rauf A, Rahman MM. Potential therapeutics against neurological disorders: natural products-based drugs. Front Pharmacol. 2022;13:950457. https:\/\/doi.org\/10.3389\/fphar.2022.950457.","journal-title":"Front Pharmacol"},{"key":"764_CR6","unstructured":"World Spider Catalog. World Spider Catalog. Version 26.0. Natural History Museum Bern. 2025. https:\/\/wsc.nmbe.ch. Accessed 23 Oct 2025."},{"key":"764_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/frchs.2023.1101141","volume":"2","author":"I Agnarsson","year":"2023","unstructured":"Agnarsson I. Grand challenges in research on arachnid diversity, conservation, and biogeography. Front Arachnid Sci. 2023;2:1101141. https:\/\/doi.org\/10.3389\/frchs.2023.1101141.","journal-title":"Front Arachnid Sci"},{"key":"764_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-387668-3.00001-5","volume":"41","author":"L Kuhn-Nentwig","year":"2011","unstructured":"Kuhn-Nentwig L, St\u00f6cklin R, Nentwig W. Venom composition and strategies in spiders: is everything possible? Adv Insect Physiol. 2011;41:1\u201386. https:\/\/doi.org\/10.1016\/B978-0-12-387668-3.00001-5.","journal-title":"Adv Insect Physiol."},{"key":"764_CR9","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1146\/annurev-ento-120811-153650","volume":"58","author":"GF King","year":"2013","unstructured":"King GF, Hardy MC. Spider-venom peptides: structure, pharmacology, and potential for control of insect pests. Annu Rev Entomol. 2013;58:475\u201396. https:\/\/doi.org\/10.1146\/annurev-ento-120811-153650.","journal-title":"Annu Rev Entomol"},{"issue":"21","key":"764_CR10","doi-asserted-by":"publisher","first-page":"11399","DOI":"10.1073\/pnas.1914536117","volume":"117","author":"SS Pineda","year":"2020","unstructured":"Pineda SS, Chin YK-Y, Undheim EAB, Senff S, Mobli M, Dauly C, et al. Structural venomics reveals evolution of a complex venom by duplication and diversification of an ancient peptide-encoding gene. Proc Natl Acad Sci USA. 2020;117(21):11399\u2013408. https:\/\/doi.org\/10.1073\/pnas.1914536117.","journal-title":"Proc Natl Acad Sci USA"},{"key":"764_CR11","unstructured":"ArachnoServer: A database of protein toxins from spiders [Database]. Brisbane (AU): The University of Queensland. https:\/\/arachnoserver.qfab.org\/mainMenu.html. Accessed 23 Oct 2025."},{"key":"764_CR12","doi-asserted-by":"publisher","DOI":"10.1590\/1678-9199-JVATITD-2021-0017","volume":"28","author":"T Barth","year":"2022","unstructured":"Barth T, Silva A, Setubal Dos Santos S, Lima Santos J, Diniz Andrade P, Tsai J, et al. Antimicrobial activity and partial chemical structure of acylpolyamines isolated from the venom of the spider Acanthoscurria natalensis. J Venom Anim Toxins Incl Trop Dis. 2022;28:e20210017. https:\/\/doi.org\/10.1590\/1678-9199-JVATITD-2021-0017.","journal-title":"J Venom Anim Toxins Incl Trop Dis"},{"issue":"6","key":"764_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/toxins16060234","volume":"16","author":"G R\u00e1dis-Baptista","year":"2024","unstructured":"R\u00e1dis-Baptista G, Konno K. Spider and wasp acylpolyamines: venom components and versatile pharmacological leads, probes, and insecticidal agents. Toxins. 2024;16(6):234. https:\/\/doi.org\/10.3390\/toxins16060234.","journal-title":"Toxins"},{"issue":"1","key":"764_CR14","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1039\/B603083C","volume":"24","author":"G Estrada","year":"2007","unstructured":"Estrada G, Villegas E, Corzo G. Spider venoms: a rich source of acylpolyamines and peptides as new leads for CNS drugs. Nat Prod Rep. 2007;24(1):145\u201361. https:\/\/doi.org\/10.1039\/B603083C.","journal-title":"Nat Prod Rep"},{"key":"764_CR15","doi-asserted-by":"publisher","DOI":"10.1590\/1678-9199-JVATITD-2021-0026","volume":"27","author":"S Diochot","year":"2021","unstructured":"Diochot S. Pain-related toxins in scorpion and spider venoms: a face to face with ion channels. J Venom Anim Toxins Incl Trop Dis. 2021;27:e20210026. https:\/\/doi.org\/10.1590\/1678-9199-JVATITD-2021-0026.","journal-title":"J Venom Anim Toxins Incl Trop Dis"},{"key":"764_CR16","doi-asserted-by":"publisher","DOI":"10.1590\/1678-9199-JVATITD-2020-0188","volume":"27","author":"LH Gremski","year":"2021","unstructured":"Gremski LH, Matsubara FH, da Justa HC, Schemczssen-Graeff Z, Baldissera AB, Schluga PH, et al. Brown spider venom toxins: what are the functions of astacins, serine proteases, hyaluronidases, allergens, TCTP, serpins and knottins? J Venom Anim Toxins Incl Trop Dis. 2021;27:e20200188. https:\/\/doi.org\/10.1590\/1678-9199-JVATITD-2020-0188.","journal-title":"J Venom Anim Toxins Incl Trop Dis"},{"issue":"8","key":"764_CR17","doi-asserted-by":"publisher","first-page":"707","DOI":"10.2174\/0929866523666160511151320","volume":"23","author":"X Wang","year":"2016","unstructured":"Wang X, Wang G. Insights into antimicrobial peptides from spiders and scorpions. Protein Pept Lett. 2016;23(8):707\u201321. https:\/\/doi.org\/10.2174\/0929866523666160511151320.","journal-title":"Protein Pept Lett"},{"issue":"2","key":"764_CR18","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/1097-4547(20001015)62:2<177::AID-JNR3>3.0.CO;2-D","volume":"62","author":"BC Albensi","year":"2000","unstructured":"Albensi BC, Alasti N, Mueller AL. Long-term potentiation in the presence of NMDA receptor antagonist arylalkylamine spider toxins. J Neurosci Res. 2000;62(2):177\u201385. https:\/\/doi.org\/10.1002\/1097-4547(20001015)62:2%3c177::AID-JNR3%3e3.0.CO;2-D.","journal-title":"J Neurosci Res"},{"issue":"1","key":"764_CR19","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jmb.2014.05.017","volume":"427","author":"MH Poulsen","year":"2015","unstructured":"Poulsen MH, Andersen J, Christensen R, Hansen KB, Traynelis SF, Str\u00f8mgaard K, et al. Binding of ArgTX-636 in the NMDA receptor ion channel. J Mol Biol. 2015;427(1):176\u201389. https:\/\/doi.org\/10.1016\/j.jmb.2014.05.017.","journal-title":"J Mol Biol"},{"issue":"2","key":"764_CR20","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/BF01056967","volume":"21","author":"NI Kiskin","year":"1989","unstructured":"Kiskin NI, Kliuchko EM, Kryshtal\u2019 OA, Tsyndrenko AIa, Akaike N. Blocking action of Nephila clavata spider toxin on ionic currents activated by glutamate and its agonists in isolated hippocampal neurons. Neurophysiology. 1989;21(2):110\u20136. https:\/\/doi.org\/10.1007\/BF01056967.","journal-title":"Neurophysiology"},{"key":"764_CR21","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s004240050612","volume":"436","author":"GM Nicholson","year":"1998","unstructured":"Nicholson GM, Walsh R, Little MJ, Tyler MI. Characterisation of the effects of robustoxin, the lethal neurotoxin from the Sydney funnel-web spider Atrax robustus, on sodium channel activation and inactivation. Pfl\u00fcgers Archiv Eur J Physiol. 1998;436:117\u201326. https:\/\/doi.org\/10.1007\/s004240050612.","journal-title":"Pfl\u00fcgers Archiv Eur J Physiol"},{"issue":"2","key":"764_CR22","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1124\/mol.105.015941","volume":"69","author":"F Bosmans","year":"2006","unstructured":"Bosmans F, Rash L, Zhu S, Diochot S, Lazdunski M, Escoubas P, et al. Four novel tarantula toxins as selective modulators of voltage-gated sodium channel subtypes. Mol Pharmacol. 2006;69(2):419\u201329. https:\/\/doi.org\/10.1124\/mol.105.015941.","journal-title":"Mol Pharmacol"},{"issue":"9","key":"764_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0182848","volume":"12","author":"SR Sousa","year":"2017","unstructured":"Sousa SR, Wingerd JS, Brust A, Bladen C, Ragnarsson L, Herzig V, et al. Discovery and mode of action of a novel analgesic \u03b2-toxin from the African spider Ceratogyrus darlingi. PLoS ONE. 2017;12(9):e0182848. https:\/\/doi.org\/10.1371\/journal.pone.0182848.","journal-title":"PLoS ONE"},{"issue":"23","key":"764_CR24","doi-asserted-by":"publisher","first-page":"9041","DOI":"10.1074\/jbc.RA118.002553","volume":"293","author":"AJ Agwa","year":"2018","unstructured":"Agwa AJ, Peigneur S, Chow CY, Lawrence N, Craik DJ, Tytgat J, et al. Gating modifier toxins isolated from spider venom: modulation of voltage-gated sodium channels and the role of lipid membranes. J Biol Chem. 2018;293(23):9041\u201352. https:\/\/doi.org\/10.1074\/jbc.RA118.002553.","journal-title":"J Biol Chem"},{"issue":"42","key":"764_CR25","doi-asserted-by":"publisher","first-page":"32293","DOI":"10.1074\/jbc.M110.104265","volume":"285","author":"AA Vassilevski","year":"2010","unstructured":"Vassilevski AA, Fedorova IM, Maleeva EE, Korolkova YV, Efimova SS, Samsonova OV, et al. Novel class of spider toxin: active principle from the yellow sac spider Cheiracanthium punctorium venom is a unique two-domain polypeptide. J Biol Chem. 2010;285(42):32293\u2013302. https:\/\/doi.org\/10.1074\/jbc.M110.104265.","journal-title":"J Biol Chem"},{"issue":"10","key":"764_CR26","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1111\/bph.13081","volume":"172","author":"JK Klint","year":"2015","unstructured":"Klint JK, Smith JJ, Vetter I, Rupasinghe DB, Er SY, Senff S, et al. Seven novel modulators of the analgesic target NaV1.7 uncovered using a high-throughput venom-based discovery approach. Br J Pharmacol. 2015;172(10):2445\u201358. https:\/\/doi.org\/10.1111\/bph.13081.","journal-title":"Br J Pharmacol"},{"issue":"30","key":"764_CR27","doi-asserted-by":"publisher","first-page":"25640","DOI":"10.1074\/jbc.M112.339051","volume":"287","author":"L Kuhn-Nentwig","year":"2012","unstructured":"Kuhn-Nentwig L, Fedorova IM, L\u00fcscher BP, Kopp LS, Trachsel C, Schaller J, et al. A venom-derived neurotoxin, CsTx-1, from the spider Cupiennius salei exhibits cytolytic activities. J Biol Chem. 2012;287(30):25640\u20139. https:\/\/doi.org\/10.1074\/jbc.M112.339051.","journal-title":"J Biol Chem"},{"issue":"3","key":"764_CR28","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3390\/toxins8030078","volume":"8","author":"JR Deuis","year":"2016","unstructured":"Deuis JR, Wingerd JS, Winter Z, Durek T, Dekan Z, Sousa SR, et al. Analgesic effects of GpTx-1, PF-04856264 and CNV1014802 in a mouse model of Na_V1.7-mediated pain. Toxins. 2016;8(3):78. https:\/\/doi.org\/10.3390\/toxins8030078.","journal-title":"Toxins"},{"issue":"9","key":"764_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/toxins13090621","volume":"13","author":"T Kimura","year":"2021","unstructured":"Kimura T. Stability and safety of inhibitor cystine knot peptide, GTx1-15, from the tarantula spider Grammostola rosea. Toxins. 2021;13(9):621. https:\/\/doi.org\/10.3390\/toxins13090621.","journal-title":"Toxins"},{"key":"764_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116175","volume":"228","author":"E Budusan","year":"2024","unstructured":"Budusan E, Payne CD, Gonzalez TI, Obergrussberger A, Becker N, Clark RJ, et al. The funnel-web spider venom derived single knot peptide Hc3a modulates acid-sensing ion channel 1a desensitisation. Biochem Pharmacol. 2024;228:116175. https:\/\/doi.org\/10.1016\/j.bcp.2024.116175.","journal-title":"Biochem Pharmacol"},{"key":"764_CR31","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/bs.pmbts.2015.01.002","volume":"131","author":"AD Mickle","year":"2015","unstructured":"Mickle AD, Shepherd AJ, Mohapatra DP. Sensory TRP channels: the key transducers of nociception and pain. Prog Mol Biol Transl Sci. 2015;131:73\u2013118. https:\/\/doi.org\/10.1016\/bs.pmbts.2015.01.002.","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"14","key":"764_CR32","doi-asserted-by":"publisher","first-page":"3750","DOI":"10.1073\/pnas.1614728114","volume":"114","author":"IR Chassagnon","year":"2017","unstructured":"Chassagnon IR, McCarthy CA, Chin YK-Y, Pineda SS, Keramidas A, Mobli M, et al. Potent neuroprotection after stroke afforded by a double-knot spider-venom peptide that inhibits acid-sensing ion channel 1a. Proc Natl Acad Sci USA. 2017;114(14):3750\u20135. https:\/\/doi.org\/10.1073\/pnas.1614728114.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"764_CR33","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/S0969-2126(97)00301-8","volume":"5","author":"JI Fletcher","year":"1997","unstructured":"Fletcher JI, Chapman BE, Mackay JP, Howden MEH, King GF. The structure of versutoxin (\u03b4-atracotoxin-Hv1) provides insights into the binding of site 3 neurotoxins to the voltage-gated sodium channel. Structure. 1997;5(11):1525\u201335. https:\/\/doi.org\/10.1016\/S0969-2126(97)00301-8.","journal-title":"Structure"},{"key":"764_CR34","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.neuropharm.2017.04.008","volume":"127","author":"MJ Windley","year":"2017","unstructured":"Windley MJ, Vetter I, Lewis RJ, Nicholson GM. Lethal effects of an insecticidal spider venom peptide involve positive allosteric modulation of insect nicotinic acetylcholine receptors. Neuropharmacology. 2017;127:224\u201342. https:\/\/doi.org\/10.1016\/j.neuropharm.2017.04.008.","journal-title":"Neuropharmacology"},{"issue":"1","key":"764_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/toxins9010007","volume":"9","author":"P Meng","year":"2016","unstructured":"Meng P, Huang H, Wang G, Yang S, Lu Q, Liu J, et al. A novel toxin from Haplopelma lividum selectively inhibits the Nav1.8 channel and possesses potent analgesic efficacy. Toxins (Basel). 2016;9(1):7. https:\/\/doi.org\/10.3390\/toxins9010007.","journal-title":"Toxins (Basel)"},{"key":"764_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.113991","volume":"180","author":"CY Chow","year":"2020","unstructured":"Chow CY, Chin YKY, Ma L, Undheim EAB, Herzig V, King GF. A selective NaV1.1 activator with potential for treatment of Dravet syndrome epilepsy. Biochem Pharmacol. 2020;180:113991. https:\/\/doi.org\/10.1016\/j.bcp.2020.113991.","journal-title":"Biochem Pharmacol"},{"issue":"13","key":"764_CR37","doi-asserted-by":"publisher","first-page":"3250","DOI":"10.1093\/emboj\/19.13.3250","volume":"19","author":"M Khvotchev","year":"2000","unstructured":"Khvotchev M, S\u00fcdhof TC. \u03b1-Latrotoxin triggers transmitter release via direct insertion into the presynaptic plasma membrane. EMBO J. 2000;19(13):3250\u201362. https:\/\/doi.org\/10.1093\/emboj\/19.13.3250.","journal-title":"EMBO J"},{"issue":"4","key":"764_CR38","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1007\/s12079-023-00783-6","volume":"17","author":"Z Lei","year":"2023","unstructured":"Lei Z, Wang H, Zhai Y, Sun M, Chen S, Yin P, et al. Insights into the mediation of Ca2\u207a signaling in the promoting effects of LETX-VI on the synthesis and release of dopamine. J Cell Commun Signal. 2023;17(4):1309\u201321. https:\/\/doi.org\/10.1007\/s12079-023-00783-6.","journal-title":"J Cell Commun Signal"},{"issue":"6","key":"764_CR39","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/S0041-0101(02)00361-6","volume":"41","author":"XZ Zeng","year":"2003","unstructured":"Zeng XZ, Xiao QB, Liang SP. Purification and characterization of raventoxin-I and raventoxin-III, two neurotoxic peptides from the venom of the spider Macrothele raveni. Toxicon. 2003;41(6):651\u20136. https:\/\/doi.org\/10.1016\/S0041-0101(02)00361-6.","journal-title":"Toxicon"},{"issue":"1-2","key":"764_CR40","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0014-5793(03)01175-X","volume":"554","author":"S Gunning","year":"2003","unstructured":"Gunning S, Chong Y, Khalife AA, Hains PG, Broady KW, Nicholson GM. Isolation of \u03b4-missulenatoxin-Mb1a, the major vertebrate-active spider \u03b4-toxin from the venom of Missulena bradleyi (Actinopodidae). FEBS Lett. 2003;554(1\u20132):211\u20138. https:\/\/doi.org\/10.1016\/S0014-5793(03)01175-X.","journal-title":"FEBS Lett"},{"issue":"50","key":"764_CR41","doi-asserted-by":"publisher","first-page":"E11837","DOI":"10.1073\/pnas.1809662115","volume":"115","author":"M Geron","year":"2018","unstructured":"Geron M, Kumar R, Zhou W, Faraldo-G\u00f3mez JD, V\u00e1squez V, Priel A. TRPV1 pore turret dictates distinct DkTx and capsaicin gating. Proc Natl Acad Sci USA. 2018;115(50):E11837\u201346. https:\/\/doi.org\/10.1073\/pnas.1809662115.","journal-title":"Proc Natl Acad Sci USA"},{"key":"764_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/srep40883","volume":"7","author":"JR Deuis","year":"2017","unstructured":"Deuis JR, Dekan Z, Wingerd JS, Smith JJ, Munasinghe NR, Bhola RF, et al. Pharmacological characterisation of the highly NaV1.7 selective spider venom peptide Pn3a. Sci Rep. 2017;7:40883. https:\/\/doi.org\/10.1038\/srep40883.","journal-title":"Sci Rep"},{"issue":"7","key":"764_CR43","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1038\/sj.bjp.0705352","volume":"139","author":"ACK Fontana","year":"2003","unstructured":"Fontana ACK, de Oliveira BR, Wojewodzic MW, dos Santos WF, Coutinho-Netto J, Gr\u00fctle NJ, et al. Purification of a neuroprotective component of Parawixia bistriata spider venom that enhances glutamate uptake. Br J Pharmacol. 2003;139(7):1297\u2013309. https:\/\/doi.org\/10.1038\/sj.bjp.0705352.","journal-title":"Br J Pharmacol"},{"key":"764_CR44","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.neulet.2013.02.074","volume":"543","author":"EA Gelfuso","year":"2013","unstructured":"Gelfuso EA, Liberato JL, Cunha AOS, Mortari MR, Beleboni RO, Lopes NP, et al. Parawixin2, a novel non-selective GABA uptake inhibitor from Parawixia bistriata spider venom, inhibits pentylenetetrazole-induced chemical kindling in rats. Neurosci Lett. 2013;543:12\u20136. https:\/\/doi.org\/10.1016\/j.neulet.2013.02.074.","journal-title":"Neurosci Lett"},{"issue":"2","key":"764_CR45","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.yebeh.2011.05.008","volume":"22","author":"HA Fachim","year":"2011","unstructured":"Fachim HA, Cunha AOS, Pereira AC, Beleboni RO, Gobbo-Neto L, Lopes NP, et al. Neurobiological activity of Parawixin 10, a novel anticonvulsant compound isolated from Parawixia bistriata spider venom (Araneidae: Araneae). Epilepsy Behav. 2011;22(2):158\u201364. https:\/\/doi.org\/10.1016\/j.yebeh.2011.05.008.","journal-title":"Epilepsy Behav"},{"key":"764_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2019.00306","volume":"13","author":"H Tenza-Ferrer","year":"2019","unstructured":"Tenza-Ferrer H, Magno LAV, Romano-Silva MA, da Silva JF, Gomez MV. Ph\u03b11\u03b2 spider toxin reverses glial structural plasticity upon peripheral inflammation. Front Cell Neurosci. 2019;13:306. https:\/\/doi.org\/10.3389\/fncel.2019.00306.","journal-title":"Front Cell Neurosci"},{"issue":"7","key":"764_CR47","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.toxicon.2008.02.010","volume":"51","author":"KP Nunes","year":"2008","unstructured":"Nunes KP, Costa-Gon\u00e7alves A, Lanza LF, Cortes SF, Cordeiro MN, Richardson M, et al. Tx2-6 toxin of the Phoneutria nigriventer spider potentiates rat erectile function. Toxicon. 2008;51(7):1197\u2013206. https:\/\/doi.org\/10.1016\/j.toxicon.2008.02.010.","journal-title":"Toxicon"},{"key":"764_CR48","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.toxicon.2013.08.059","volume":"76","author":"GM Gomes","year":"2013","unstructured":"Gomes GM, Dalmolin GD, Cordeiro MN, Gomez MV, Ferreira J, Rubin MA. The selective A-type K\u207a current blocker Tx3-1 isolated from the Phoneutria nigriventer venom enhances memory of na\u00efve and A\u03b2(25-35)-treated mice. Toxicon. 2013;76:23\u20137. https:\/\/doi.org\/10.1016\/j.toxicon.2013.08.059.","journal-title":"Toxicon"},{"issue":"10","key":"764_CR49","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1016\/j.pain.2011.04.015","volume":"152","author":"GD Dalmolin","year":"2011","unstructured":"Dalmolin GD, Silva CR, Rigo FK, Gomes GM, do Nascimento Cordeiro M, Richardson M, et al. Antinociceptive effect of Brazilian armed spider venom toxin Tx3-3 in animal models of neuropathic pain. Pain. 2011;152(10):2224\u201332. https:\/\/doi.org\/10.1016\/j.pain.2011.04.015.","journal-title":"Pain"},{"issue":"2","key":"764_CR50","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.neulet.2008.05.019","volume":"434","author":"CJ de Castro Jr","year":"2008","unstructured":"de Castro Jr CJ, Pinheiro ACN, Guatimosim C, Cordeiro MN, Souza AH, Gomes Dod RD, et al. Tx3-4, a calcium-channel-blocking toxin from the venom of the spider Phoneutria nigriventer. Neurosci Lett. 2008;434(2):154\u20138. https:\/\/doi.org\/10.1016\/j.neulet.2008.05.019.","journal-title":"Neurosci Lett"},{"issue":"8","key":"764_CR51","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1113\/EP090327","volume":"107","author":"JV Joviano-Santos","year":"2022","unstructured":"Joviano-Santos JV, Valad\u00e3o PAC, Magalh\u00e3es-Gomes MPS, Fernandes LF, Diniz DM, Machado TCG, et al. Neuroprotective effect of CTK 01512-2 recombinant toxin at the spinal cord in a model of Huntington\u2019s disease. Exp Physiol. 2022;107(8):933\u201345. https:\/\/doi.org\/10.1113\/EP090327.","journal-title":"Exp Physiol"},{"key":"764_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxcx.2023.100151","volume":"18","author":"LF D\u00edaz-Pe\u00f1a","year":"2023","unstructured":"D\u00edaz-Pe\u00f1a LF, Torres-Ortiz JD, Aguilar MB, Luis E, Lazcano-P\u00e9rez FJ, Arregu\u00edn-Espinosa R, et al. A subfraction obtained from the venom of the tarantula Poecilotheria regalis contains inhibitor cystine knot peptides and induces relaxation of rat aorta by inhibiting L-type voltage-gated calcium channels. Toxicon X. 2023;18:100151. https:\/\/doi.org\/10.1016\/j.toxcx.2023.100151.","journal-title":"Toxicon X."},{"issue":"8","key":"764_CR53","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/nn1940","volume":"10","author":"M Mazzuca","year":"2007","unstructured":"Mazzuca M, Heurteaux C, Alloui A, Diochot S, Baron A, Voilley N, et al. A tarantula peptide against pain via ASIC1a channels and opioid mechanisms. Nat Neurosci. 2007;10(8):943\u20135. https:\/\/doi.org\/10.1038\/nn1940.","journal-title":"Nat Neurosci"},{"key":"764_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-01129-0","volume":"7","author":"JS Wingerd","year":"2017","unstructured":"Wingerd JS, Ussing CA, Murali SS, Chin Y-K-Y, Cristofori-Armstrong B, Durek T, et al. The tarantula toxin \u03b2\/\u03b4-TRTX-Pre1a highlights the importance of the S1-S2 voltage-sensor region for sodium channel subtype selectivity. Sci Rep. 2017;7:974. https:\/\/doi.org\/10.1038\/s41598-017-01129-0.","journal-title":"Sci Rep"},{"issue":"5","key":"764_CR55","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1007\/s00018-003-2354-x","volume":"60","author":"Z Liu","year":"2003","unstructured":"Liu Z, Dai J, Chen Z, Hu W, Xiao Y, Liang S. Isolation and characterization of hainantoxin-IV, a novel antagonist of tetrodotoxin-sensitive sodium channels from the Chinese bird spider Selenocosmia hainana. Cell Mol Life Sci. 2003;60(5):972\u20138. https:\/\/doi.org\/10.1007\/s00018-003-2354-x.","journal-title":"Cell Mol Life Sci"},{"issue":"51","key":"764_CR56","doi-asserted-by":"publisher","first-page":"47564","DOI":"10.1074\/jbc.M204063200","volume":"277","author":"K Peng","year":"2002","unstructured":"Peng K, Shu Q, Liu Z, Liang SP. Function and solution structure of huwentoxin-IV, a potent neuronal tetrodotoxin-sensitive sodium channel antagonist from Chinese bird spider Selenocosmia huwena. J Biol Chem. 2002;277(51):47564\u201371. https:\/\/doi.org\/10.1074\/jbc.M204063200.","journal-title":"J Biol Chem"},{"key":"764_CR57","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.toxicon.2022.08.003","volume":"217","author":"N Monfared","year":"2022","unstructured":"Monfared N, Ahadiyat A, Fathipour Y, Arabi Mianroodi R. Evaluation of recombinant toxin JFTX-23, an oral-effective anti-insect peptide from the spider Selenocosmia jiafu venom gland proteome. Toxicon. 2022;217:78\u201386. https:\/\/doi.org\/10.1016\/j.toxicon.2022.08.003.","journal-title":"Toxicon"},{"issue":"2","key":"764_CR58","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1097\/j.pain.0000000000002041","volume":"162","author":"FC Cardoso","year":"2021","unstructured":"Cardoso FC, Castro J, Grundy L, Schober G, Garcia-Caraballo S, Zhao T, et al. A spider-venom peptide with multitarget activity on sodium and calcium channels alleviates chronic visceral pain in a model of irritable bowel syndrome. Pain. 2021;162(2):569\u201381. https:\/\/doi.org\/10.1097\/j.pain.0000000000002041.","journal-title":"Pain"},{"issue":"6","key":"764_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/toxins11060367","volume":"11","author":"S Nicolas","year":"2019","unstructured":"Nicolas S, Zoukimian C, Bosmans F, Montnach J, Diochot S, Cuypers E, et al. Chemical synthesis, proper folding, Nav channel selectivity profile and analgesic properties of the spider peptide Phlotoxin 1. Toxins. 2019;11(6):367. https:\/\/doi.org\/10.3390\/toxins11060367.","journal-title":"Toxins"},{"key":"764_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/1756-6606-7-36","volume":"7","author":"C Bladen","year":"2014","unstructured":"Bladen C, Hamid J, Souza IA, Zamponi GW. Block of T-type calcium channels by protoxins I and II. Mol Brain. 2014;7:36. https:\/\/doi.org\/10.1186\/1756-6606-7-36.","journal-title":"Mol Brain"},{"key":"764_CR61","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.toxicon.2013.04.020","volume":"70","author":"TAA Rocha-E-Silva","year":"2013","unstructured":"Rocha-E-Silva TAA, Rostelato-Ferreira S, Leite GB, da Silva Jr PI, Hyslop S, Rodrigues-Simioni L. VdTX-1, a reversible nicotinic receptor antagonist isolated from venom of the spider Vitalius dubius (Theraphosidae). Toxicon. 2013;70:135\u201341. https:\/\/doi.org\/10.1016\/j.toxicon.2013.04.020.","journal-title":"Toxicon"},{"issue":"2","key":"764_CR62","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/0006-8993(90)91243-A","volume":"526","author":"H Jackson","year":"1990","unstructured":"Jackson H, Parks TN. Anticonvulsant action of an arylamine-containing fraction from Agelenopsis spider venom. Brain Res. 1990;526(2):338\u201341. https:\/\/doi.org\/10.1016\/0006-8993(90)91243-A.","journal-title":"Brain Res"},{"key":"764_CR63","doi-asserted-by":"publisher","DOI":"10.1590\/1678-9199-JVATITD-2021-0009","volume":"27","author":"SMM Lopez","year":"2021","unstructured":"Lopez SMM, Aguilar JS, Fernandez JBB, Lao AGJ, Estrella MRR, Devanadera MKP, et al. Neuroactive venom compounds obtained from Phlogiellus bundokalbo as potential leads for neurodegenerative diseases: insights on their acetylcholinesterase and beta-secretase inhibitory activities in vitro. J Venom Anim Toxins Incl Trop Dis. 2021;27:e20210009. https:\/\/doi.org\/10.1590\/1678-9199-JVATITD-2021-0009.","journal-title":"J Venom Anim Toxins Incl Trop Dis"},{"issue":"2","key":"764_CR64","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3390\/toxins3020142","volume":"3","author":"LMM Cesar-Tognoli","year":"2011","unstructured":"Cesar-Tognoli LMM, Salamoni SD, Tavares AA, Elias CF, da Costa JC, Bittencourt JC, et al. Effects of spider venom toxin PWTX-I (6-hydroxytrypargine) on the central nervous system of rats. Toxins. 2011;3(2):142\u201362. https:\/\/doi.org\/10.3390\/toxins3020142.","journal-title":"Toxins"},{"issue":"10","key":"764_CR65","doi-asserted-by":"publisher","first-page":"R603","DOI":"10.1016\/j.cub.2020.04.008","volume":"30","author":"D Arendt","year":"2020","unstructured":"Arendt D. The evolutionary assembly of neuronal machinery. Curr Biol. 2020;30(10):R603\u201316. https:\/\/doi.org\/10.1016\/j.cub.2020.04.008.","journal-title":"Curr Biol"},{"issue":"5","key":"764_CR66","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nchembio.2353","volume":"13","author":"WA Catterall","year":"2017","unstructured":"Catterall WA, Wisedchaisri G, Zheng N. The chemical basis for electrical signaling. Nat Chem Biol. 2017;13(5):455\u201363. https:\/\/doi.org\/10.1038\/nchembio.2353.","journal-title":"Nat Chem Biol"},{"issue":"1","key":"764_CR67","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.neuron.2014.03.016","volume":"82","author":"BA Simms","year":"2014","unstructured":"Simms BA, Zamponi GW. Neuronal voltage-gated calcium channels: structure, function, and dysfunction. Neuron. 2014;82(1):24\u201345. https:\/\/doi.org\/10.1016\/j.neuron.2014.03.016.","journal-title":"Neuron"},{"issue":"2","key":"764_CR68","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3724\/zdxbyxb-2023-0472","volume":"53","author":"Y Lu","year":"2024","unstructured":"Lu Y, Lin Y, Wang J. Progress on functions of intracellular domain of trimeric ligand-gated ion channels. J Zhejiang Univ (Med Sci). 2024;53(2):221\u201330. https:\/\/doi.org\/10.3724\/zdxbyxb-2023-0472.","journal-title":"J Zhejiang Univ (Med Sci)"},{"issue":"9","key":"764_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094810","volume":"22","author":"N Ruan","year":"2021","unstructured":"Ruan N, Tribble J, Peterson AM, Jiang Q, Wang JQ, Chu X-P. Acid-sensing ion channels and mechanosensation. Int J Mol Sci. 2021;22(9):4810. https:\/\/doi.org\/10.3390\/ijms22094810.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"764_CR70","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1124\/pr.108.000869","volume":"63","author":"AS Kristensen","year":"2011","unstructured":"Kristensen AS, Andersen J, J\u00f8rgensen TN, S\u00f8rensen L, Eriksen J, Loland CJ, et al. SLC6 neurotransmitter transporters: structure, function, and regulation. Pharmacol Rev. 2011;63(3):585\u2013640. https:\/\/doi.org\/10.1124\/pr.108.000869.","journal-title":"Pharmacol Rev"},{"issue":"3","key":"764_CR71","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2174\/1570159X11311030006","volume":"11","author":"MB \u010colovi\u0107","year":"2013","unstructured":"\u010colovi\u0107 MB, Krsti\u0107 DZ, Lazarevi\u0107-Pa\u0161ti TD, Bond\u017ei\u0107 AM, Vasi\u0107 VM. Acetylcholinesterase inhibitors: pharmacology and toxicology. Curr Neuropharmacol. 2013;11(3):315\u201335. https:\/\/doi.org\/10.2174\/1570159X11311030006.","journal-title":"Curr Neuropharmacol"},{"issue":"11","key":"764_CR72","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1517\/14712598.2011.621940","volume":"11","author":"GF King","year":"2011","unstructured":"King GF. Venoms as a platform for human drugs: translating toxins into therapeutics. Expert Opin Biol Ther. 2011;11(11):1469\u201384. https:\/\/doi.org\/10.1517\/14712598.2011.621940.","journal-title":"Expert Opin Biol Ther"},{"issue":"7","key":"764_CR73","doi-asserted-by":"publisher","DOI":"10.3390\/toxins15070451","volume":"15","author":"JD Romano","year":"2023","unstructured":"Romano JD, Li H, Napolitano T, Realubit R, Karan C, Holford M, et al. Discovering venom-derived drug candidates using differential gene expression. Toxins. 2023;15(7):451. https:\/\/doi.org\/10.3390\/toxins15070451.","journal-title":"Toxins"},{"issue":"1","key":"764_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-024-00432-x","volume":"13","author":"E Liu","year":"2024","unstructured":"Liu E, Zhang Y, Wang JZ. Updates in Alzheimer\u2019s disease: from basic research to diagnosis and therapies. Transl Neurodegener. 2024;13(1):45. https:\/\/doi.org\/10.1186\/s40035-024-00432-x.","journal-title":"Transl Neurodegener"},{"key":"764_CR75","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.toxicon.2018.07.008","volume":"151","author":"S Peigneur","year":"2018","unstructured":"Peigneur S, Paiva ALB, Cordeiro MN, Borges MH, Diniz MRV, De Lima ME, et al. Phoneutria nigriventer venom: a pharmacological treasure. Toxicon. 2018;151:96\u2013110. https:\/\/doi.org\/10.1016\/j.toxicon.2018.07.008.","journal-title":"Toxicon"},{"key":"764_CR76","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/978-3-540-74805-2_7","volume":"184","author":"YA Ushkaryov","year":"2008","unstructured":"Ushkaryov YA, Rohou A, Sugita S. alpha-Latrotoxin and its receptors. Handb Exp Pharmacol. 2008;184:171\u2013206. https:\/\/doi.org\/10.1007\/978-3-540-74805-2_7.","journal-title":"Handb Exp Pharmacol"},{"issue":"9","key":"764_CR77","doi-asserted-by":"publisher","first-page":"754","DOI":"10.2174\/1389557519666191104110908","volume":"20","author":"BLB Marino","year":"2020","unstructured":"Marino BLB, de Souza LR, Sousa KPA, Ferreira JV, Padilha EC, da Silva CHTP, et al. Parkinson\u2019s disease: a review from pathophysiology to treatment. Mini Rev Med Chem. 2020;20(9):754\u201367. https:\/\/doi.org\/10.2174\/1389557519666191104110908.","journal-title":"Mini Rev Med Chem"},{"issue":"s2","key":"764_CR78","doi-asserted-by":"publisher","first-page":"S257","DOI":"10.3233\/JPD-230411","volume":"14","author":"K Kulcsarova","year":"2024","unstructured":"Kulcsarova K, Skorvanek M, Postuma RB, Berg D. Defining Parkinson\u2019s disease: past and future. J Parkinsons Dis. 2024;14(s2):S257\u201371. https:\/\/doi.org\/10.3233\/JPD-230411.","journal-title":"J Parkinsons Dis"},{"issue":"8","key":"764_CR79","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s00702-017-1875-5","volume":"125","author":"E Tronci","year":"2018","unstructured":"Tronci E, Francardo V. Animal models of l-DOPA-induced dyskinesia: the 6-OHDA-lesioned rat and mouse. J Neural Transm (Vienna). 2018;125(8):1137\u201344. https:\/\/doi.org\/10.1007\/s00702-017-1875-5.","journal-title":"J Neural Transm (Vienna)"},{"key":"764_CR80","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.toxicon.2016.01.056","volume":"112","author":"F G\u00f3mez-Lagunas","year":"2016","unstructured":"G\u00f3mez-Lagunas F, Arreola-Silva A, L\u00f3renz-M\u00e9ndez V, Corzo G. The Phoneutria nigriventer spider toxin, PnTx4-5-5, promotes neuronal survival by blocking NMDA receptors. Toxicon. 2016;112:52\u20138. https:\/\/doi.org\/10.1016\/j.toxicon.2016.01.056.","journal-title":"Toxicon"},{"issue":"2","key":"764_CR81","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.toxicon.2006.09.014","volume":"49","author":"BT Priest","year":"2007","unstructured":"Priest BT, Blumenthal KM, Smith JJ, Warren VA, Smith MM. ProTx-I and ProTx-II: gating modifiers of voltage-gated sodium channels. Toxicon. 2007;49(2):194\u2013201. https:\/\/doi.org\/10.1016\/j.toxicon.2006.09.014.","journal-title":"Toxicon"},{"issue":"1","key":"764_CR82","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s12975-013-0305-y","volume":"5","author":"XP Chu","year":"2014","unstructured":"Chu XP, Grasing KA, Wang JQ. Acid-sensing ion channels contribute to neurotoxicity. Transl Stroke Res. 2014;5(1):69\u201378. https:\/\/doi.org\/10.1007\/s12975-013-0305-y.","journal-title":"Transl Stroke Res"},{"issue":"8","key":"764_CR83","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.22825","volume":"35","author":"X Tang","year":"2021","unstructured":"Tang X, Yu D, Wang H, Meng W, Lei Z, Zhai Y, et al. Biochemical and cytotoxic evaluation of latroeggtoxin-VI against PC12 cells. J Biochem Mol Toxicol. 2021;35(8):e22825. https:\/\/doi.org\/10.1002\/jbt.22825.","journal-title":"J Biochem Mol Toxicol"},{"key":"764_CR84","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.ijbiomac.2022.07.208","volume":"216","author":"Y Gao","year":"2022","unstructured":"Gao Y, Ma W, Lei Z, Yu D, Wang H, Yan J, et al. Insights into the mediation of Ca2+ signaling in the promoting effects of Latroeggtoxin-VI on the synthesis and release of dopamine. Int J Biol Macromol. 2022;216:906\u201315. https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.07.208.","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"764_CR85","doi-asserted-by":"publisher","DOI":"10.1186\/s40659-024-00489-y","volume":"57","author":"D Yu","year":"2024","unstructured":"Yu D, Wang H, Zhai Y, Lei Z, Sun M, Chen S, et al. Effects of latroeggtoxin-VI on dopamine and \u03b1-synuclein in PC12 cells and the implications for Parkinson\u2019s disease. Biol Res. 2024;57(1):9. https:\/\/doi.org\/10.1186\/s40659-024-00489-y.","journal-title":"Biol Res"},{"issue":"4","key":"764_CR86","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1097\/WCO.0b013e328304b692","volume":"21","author":"E Roze","year":"2008","unstructured":"Roze E, Saudou F, Caboche J. Pathophysiology of Huntington\u02bcs disease: from huntingtin functions to potential treatments: Curr Opin Neurol. 2008;21(4):497\u2013503. https:\/\/doi.org\/10.1097\/WCO.0b013e328304b692.","journal-title":"Curr Opin Neurol"},{"key":"764_CR87","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.neuro.2021.08.016","volume":"87","author":"FTT Antunes","year":"2021","unstructured":"Antunes FTT, de Souza AH, Caminski ES, Greggio S, Venturin GT, da Costa JC, et al. Neuroprotective effects of the CTK 01512-2 toxin against neurotoxicity induced by 3-nitropropionic acid in rats. Neurotoxicology. 2021;87:30\u201342. https:\/\/doi.org\/10.1016\/j.neuro.2021.08.016.","journal-title":"Neurotoxicology"},{"issue":"2","key":"764_CR88","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1159\/000503831","volume":"54","author":"E Beghi","year":"2020","unstructured":"Beghi E. The epidemiology of epilepsy. Neuroepidemiology. 2020;54(2):185\u201391. https:\/\/doi.org\/10.1159\/000503831.","journal-title":"Neuroepidemiology"},{"issue":"1","key":"764_CR89","doi-asserted-by":"publisher","DOI":"10.1186\/s42494-023-00137-0","volume":"5","author":"KT Sumadewi","year":"2023","unstructured":"Sumadewi KT, Harkitasari S, Tjandra DC. Biomolecular mechanisms of epileptic seizures and epilepsy: a review. Acta Epileptologica. 2023;5(1):28. https:\/\/doi.org\/10.1186\/s42494-023-00137-0.","journal-title":"Acta Epileptologica"},{"issue":"1","key":"764_CR90","doi-asserted-by":"publisher","DOI":"10.1186\/s42494-021-00055-z","volume":"3","author":"E Perucca","year":"2021","unstructured":"Perucca E. The pharmacological treatment of epilepsy: recent advances and future perspectives. Acta Epileptologica. 2021;3(1):22. https:\/\/doi.org\/10.1186\/s42494-021-00055-z.","journal-title":"Acta Epileptologica"},{"issue":"3","key":"764_CR91","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1124\/pr.120.019539","volume":"72","author":"W L\u00f6scher","year":"2020","unstructured":"L\u00f6scher W, Potschka H, Sisodiya SM, Vezzani A. Drug resistance in epilepsy: clinical impact, potential mechanisms, and new innovative treatment options. Pharmacol Rev. 2020;72(3):606\u201338. https:\/\/doi.org\/10.1124\/pr.120.019539.","journal-title":"Pharmacol Rev"},{"issue":"1","key":"764_CR92","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/jnc.15769","volume":"165","author":"A Bryson","year":"2023","unstructured":"Bryson A, Reid C, Petrou S. Fundamental neurochemistry review: GABAA receptor neurotransmission and epilepsy: principles, disease mechanisms and pharmacotherapy. J Neurochem. 2023;165(1):6\u201328. https:\/\/doi.org\/10.1111\/jnc.15769.","journal-title":"J Neurochem"},{"key":"764_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.114043","volume":"181","author":"CY Chow","year":"2020","unstructured":"Chow CY, Absalom N, Biggs K, King GF, Ma L. Venom-derived modulators of epilepsy-related ion channels. Biochem Pharmacol. 2020;181:114043. https:\/\/doi.org\/10.1016\/j.bcp.2020.114043.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"764_CR94","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.brainres.2006.09.052","volume":"1124","author":"JL Liberato","year":"2006","unstructured":"Liberato JL, Cunha AO, Mortari MR, Gelfuso EA, Beleboni Rde O, Coutinho-Netto J, et al. Anticonvulsant and anxiolytic activity of FrPbAII, a novel GABA uptake inhibitor isolated from the venom of the social spider Parawixia bistriata (Araneidae: Araneae). Brain Res. 2006;1124(1):19\u201327. https:\/\/doi.org\/10.1016\/j.brainres.2006.09.052.","journal-title":"Brain Res"},{"issue":"6","key":"764_CR95","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1076\/phbi.40.6.472.8436","volume":"40","author":"M Cairr\u00e3o","year":"2002","unstructured":"Cairr\u00e3o M, Ribeiro AM, Pizzo AB, Fontana ACK, Beleboni RO, Coutinho-Netto J, et al. Anticonvulsant and GABA uptake inhibition properties of venom fractions from the spiders Parawixia bistriata and Scaptocosa raptoria. Pharm Biol. 2002;40(6):472\u20137. https:\/\/doi.org\/10.1076\/phbi.40.6.472.8436.","journal-title":"Pharm Biol"},{"issue":"9","key":"764_CR96","doi-asserted-by":"publisher","DOI":"10.3390\/toxins9090262","volume":"9","author":"LD Godoy","year":"2017","unstructured":"Godoy LD, Liberato JL, Celani MVB, Gobbo-Neto L, Lopes NP, Dos Santos WF. Disease modifying effects of the spider toxin Parawixin2 in the experimental epilepsy model. Toxins (Basel). 2017;9(9):262. https:\/\/doi.org\/10.3390\/toxins9090262.","journal-title":"Toxins (Basel)"},{"issue":"11","key":"764_CR97","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1113\/jphysiol.2010.188417","volume":"588","author":"VC Wimmer","year":"2010","unstructured":"Wimmer VC, Reid CA, So EY-W, Berkovic SF, Petrou S. Axon initial segment dysfunction in epilepsy. J Physiol. 2010;588(11):1829\u201340. https:\/\/doi.org\/10.1113\/jphysiol.2010.188417.","journal-title":"J Physiol"},{"issue":"16","key":"764_CR98","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1212\/WNL.0b013e3181f8812e","volume":"75","author":"Y Liao","year":"2010","unstructured":"Liao Y, Anttonen AK, Liukkonen E, Gaily E, Maljevic S, Schubert S, et al. SCN2A mutation associated with neonatal epilepsy, late-onset episodic ataxia, myoclonus, and pain. Neurology. 2010;75(16):1454\u20138. https:\/\/doi.org\/10.1212\/WNL.0b013e3181f8812e.","journal-title":"Neurology"},{"issue":"8","key":"764_CR99","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1038\/nn.2359","volume":"12","author":"W Hu","year":"2009","unstructured":"Hu W, Tian C, Li T, Yang M, Hou H, Shu Y. Distinct contributions of Nav1.6 and Nav1.2 in action potential initiation and backpropagation. Nat Neurosci. 2009;12(8):996\u20131002. https:\/\/doi.org\/10.1038\/nn.2359.","journal-title":"Nat Neurosci"},{"issue":"12","key":"764_CR100","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2020.165959","volume":"1866","author":"L Sol\u00e9","year":"2020","unstructured":"Sol\u00e9 L, Wagnon JL, Tamkun MM. Functional analysis of three Nav1.6 mutations causing early infantile epileptic encephalopathy. Biochimica et Biophysica Acta (BBA) Mol Basis of Dis. 2020;1866(12):165959. https:\/\/doi.org\/10.1016\/j.bbadis.2020.165959.","journal-title":"Biochimica et Biophysica Acta (BBA) Mol Basis of Dis"},{"issue":"5","key":"764_CR101","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1124\/mol.108.047670","volume":"74","author":"WA Schmalhofer","year":"2008","unstructured":"Schmalhofer WA, Coats BD, Miller BS, Kuduk SD, Mattern RH, Kuo GM, et al. hNav1.7 selective benzazepinone local anesthetic analogues: potent and selective inhibition of Nav1.7 channel function. Mol Pharmacol. 2008;74(5):1476\u201384. https:\/\/doi.org\/10.1124\/mol.108.047670.","journal-title":"Mol Pharmacol"},{"issue":"4","key":"764_CR102","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.pain.2013.11.013","volume":"155","author":"O van Hecke","year":"2014","unstructured":"van Hecke O, Austin SK, Khan RA, Smith BH, Torrance N. Neuropathic pain in the general population: a systematic review of epidemiological studies. Pain. 2014;155(4):654\u201362. https:\/\/doi.org\/10.1016\/j.pain.2013.11.013.","journal-title":"Pain"},{"issue":"1","key":"764_CR103","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.2","volume":"3","author":"L Colloca","year":"2017","unstructured":"Colloca L, Ludman T, Bouhassira D, Baron R, Dickenson AH, Yarnitsky D, et al. Neuropathic pain. Nat Rev Dis Primers. 2017;3(1):17002. https:\/\/doi.org\/10.1038\/nrdp.2017.2.","journal-title":"Nat Rev Dis Primers"},{"issue":"18","key":"764_CR104","doi-asserted-by":"publisher","first-page":"998","DOI":"10.21037\/atm-22-4242","volume":"10","author":"Y Li","year":"2022","unstructured":"Li Y, Zhang Y, Yu C, Sun S, Yao H, Miyoshi H, et al. Effects of high-dose opioid analgesia on survival, pain relief, quality of life and adverse drug reactions in cancer and neuropathic pain patients: a retrospective cohort study in real-world clinical practice. Ann Transl Med. 2022;10(18):998. https:\/\/doi.org\/10.21037\/atm-22-4242.","journal-title":"Ann Transl Med."},{"issue":"5","key":"764_CR105","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41583-021-00444-w","volume":"22","author":"G Goodwin","year":"2021","unstructured":"Goodwin G, McMahon SB. The physiological function of different voltage-gated sodium channels in pain. Nat Rev Neurosci. 2021;22(5):263\u201374. https:\/\/doi.org\/10.1038\/s41583-021-00444-w.","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"764_CR106","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.toxicon.2012.04.337","volume":"60","author":"JK Klint","year":"2012","unstructured":"Klint JK, Senff S, Rupasinghe DB, Er SY, Herzig V, Nicholson GM, et al. Spider-venom peptides that target voltage-gated sodium channels: pharmacological tools and potential therapeutic leads. Toxicon. 2012;60(3):478\u201391. https:\/\/doi.org\/10.1016\/j.toxicon.2012.04.337.","journal-title":"Toxicon"},{"issue":"2","key":"764_CR107","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1124\/mol.115.098178","volume":"88","author":"FC Cardoso","year":"2015","unstructured":"Cardoso FC, Dekan Z, Rosengren KJ, Erickson A, Vetter I, Deuis JR, et al. Identification and characterization of ProTx-III [\u03bc-TRTX-Tp1a], a new voltage-gated sodium channel inhibitor from venom of the tarantula Thrixopelma pruriens. Mol Pharmacol. 2015;88(2):291\u2013303. https:\/\/doi.org\/10.1124\/mol.115.098178.","journal-title":"Mol Pharmacol"},{"issue":"5","key":"764_CR108","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1021\/jm501765v","volume":"58","author":"JK Murray","year":"2015","unstructured":"Murray JK, Ligutti J, Liu D, Zou A, Poppe L, Li H. Engineering potent and selective analogues of GpTx-1, a tarantula venom peptide antagonist of the NaV1.7 sodium channel. J Med Chem. 2015;58(5):2299\u2013314. https:\/\/doi.org\/10.1021\/jm501765v.","journal-title":"J Med Chem"},{"key":"764_CR109","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00366","volume":"10","author":"FC Cardoso","year":"2019","unstructured":"Cardoso FC, Lewis RJ. Structure\u2013function and therapeutic potential of spider venom-derived cysteine knot peptides targeting sodium channels. Front Pharmacol. 2019;10:366. https:\/\/doi.org\/10.3389\/fphar.2019.00366.","journal-title":"Front Pharmacol"},{"issue":"14","key":"764_CR110","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.1111\/bph.15783","volume":"179","author":"DA Eagles","year":"2022","unstructured":"Eagles DA, Chow CY, King GF. Fifteen years of NaV1.7 channels as an analgesic target: why has excellent in vitro pharmacology not translated into in vivo analgesic efficacy? Br J Pharmacol. 2022;179(14):3592\u2013611. https:\/\/doi.org\/10.1111\/bph.15783.","journal-title":"Br J Pharmacol"},{"key":"764_CR111","doi-asserted-by":"publisher","DOI":"10.1038\/srep39662","volume":"7","author":"M Flinspach","year":"2017","unstructured":"Flinspach M, Xu Q, Piekarz AD, Fellows R, Hagan R, Gibbs A, et al. Insensitivity to pain induced by a potent selective closed-state NaV1.7 inhibitor. Sci Rep. 2017;7:39662. https:\/\/doi.org\/10.1038\/srep39662.","journal-title":"Sci Rep"},{"issue":"42","key":"764_CR112","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202406656","volume":"11","author":"S Luo","year":"2024","unstructured":"Luo S, Zhou X, Wu M, Wang G, Wang L, Feng X, et al. Optimizing NaV1.7-targeted analgesics: revealing off-target effects of spider venom-derived peptide toxins and engineering strategies for improvement. Adv Sci. 2024;11(42):e2406656. https:\/\/doi.org\/10.1002\/advs.202406656.","journal-title":"Adv Sci"},{"issue":"1","key":"764_CR113","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.33375","volume":"15","author":"G Poomalai","year":"2023","unstructured":"Poomalai G, Prabhakar S, Sirala Jagadesh N. Functional ability and health problems of stroke survivors: an explorative study. Cureus. 2023;15(1):e33375. https:\/\/doi.org\/10.7759\/cureus.33375.","journal-title":"Cureus"},{"issue":"1","key":"764_CR114","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1326-6-11","volume":"6","author":"TM Woodruff","year":"2011","unstructured":"Woodruff TM, Thundyil J, Tang SC, Sobey CG, Taylor SM, Arumugam TV. Pathophysiology, treatment, and animal and cellular models of human ischemic stroke. Mol Neurodegener. 2011;6(1):11. https:\/\/doi.org\/10.1186\/1750-1326-6-11.","journal-title":"Mol Neurodegener"},{"key":"764_CR115","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.05682","volume":"4","author":"YZ Wang","year":"2015","unstructured":"Wang YZ, Wang JJ, Huang Y, Liu F, Zeng WZ, Li Y, et al. Tissue acidosis induces neuronal necroptosis via ASIC1a channel independent of its ionic conduction. Elife. 2015;4:e05682. https:\/\/doi.org\/10.7554\/eLife.05682.","journal-title":"Elife"},{"issue":"33","key":"764_CR116","doi-asserted-by":"publisher","first-page":"25116","DOI":"10.1074\/jbc.M003643200","volume":"275","author":"P Escoubas","year":"2000","unstructured":"Escoubas P, De Weille JR, Lecoq A, Diochot S, Waldmann R, Champigny G, et al. Isolation of a tarantula toxin specific for a class of proton-gated Na+ channels. J Biol Chem. 2000;275(33):25116\u201321. https:\/\/doi.org\/10.1074\/jbc.M003643200.","journal-title":"J Biol Chem"},{"key":"764_CR117","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.neuropharm.2015.08.040","volume":"99","author":"CA McCarthy","year":"2015","unstructured":"McCarthy CA, Rash LD, Chassagnon IR, King GF, Widdop RE. PcTx1 affords neuroprotection in a conscious model of stroke in hypertensive rats via selective inhibition of ASIC1a. Neuropharmacology. 2015;99:650\u20137. https:\/\/doi.org\/10.1016\/j.neuropharm.2015.08.040.","journal-title":"Neuropharmacology"},{"issue":"9","key":"764_CR118","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094440","volume":"22","author":"G Menculini","year":"2021","unstructured":"Menculini G, Chipi E, Paolini Paoletti F, Gaetani L, Nigro P, Simoni S, et al. Insights into the pathophysiology of psychiatric symptoms in central nervous system disorders: implications for early and differential diagnosis. Int J Mol Sci. 2021;22(9):4440. https:\/\/doi.org\/10.3390\/ijms22094440.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"764_CR119","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1080\/14656566.2018.1472767","volume":"19","author":"AF Gomez","year":"2018","unstructured":"Gomez AF, Barthel AL, Hofmann SG. Comparing the efficacy of benzodiazepines and serotonergic anti-depressants for adults with generalized anxiety disorder: a meta-analytic review. Expert Opin Pharmacother. 2018;19(8):883\u201394. https:\/\/doi.org\/10.1080\/14656566.2018.1472767.","journal-title":"Expert Opin Pharmacother"},{"issue":"6","key":"764_CR120","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.toxicon.2009.05.027","volume":"54","author":"DM Saidemberg","year":"2009","unstructured":"Saidemberg DM, Ferreira MA, Takahashi TN, Gomes PC, Cesar-Tognoli LM, da Silva-Filho LC, et al. Monoamine oxidase inhibitory activities of indolylalkaloid toxins from the venom of the colonial spider Parawixia bistriata: functional characterization of PwTX-I. Toxicon. 2009;54(6):717\u201324. https:\/\/doi.org\/10.1016\/j.toxicon.2009.05.027.","journal-title":"Toxicon"},{"issue":"6","key":"764_CR121","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.lfs.2006.10.002","volume":"80","author":"EA Gelfuso","year":"2007","unstructured":"Gelfuso EA, Cunha AO, Mortari MR, Liberato JL, Paraventi KH, Beleboni RO, et al. Neuropharmacological profile of FrPbAII, purified from the venom of the social spider Parawixia bistriata (Araneae, Araneidae), in Wistar rats. Life Sci. 2007;80(6):566\u201372. https:\/\/doi.org\/10.1016\/j.lfs.2006.10.002.","journal-title":"Life Sci"},{"issue":"5","key":"764_CR122","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.toxicon.2004.02.007","volume":"43","author":"P Escoubas","year":"2004","unstructured":"Escoubas P, Rash L. Tarantulas: eight-legged pharmacists and combinatorial chemists. Toxicon. 2004;43(5):555\u201374. https:\/\/doi.org\/10.1016\/j.toxicon.2004.02.007.","journal-title":"Toxicon"},{"issue":"4","key":"764_CR123","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ucl.2021.06.009","volume":"48","author":"SM MacDonald","year":"2021","unstructured":"MacDonald SM, Burnett AL. Physiology of erection and pathophysiology of erectile dysfunction. Urol Clin North Am. 2021;48(4):513\u201325. https:\/\/doi.org\/10.1016\/j.ucl.2021.06.009.","journal-title":"Urol Clin North Am"},{"issue":"1","key":"764_CR124","doi-asserted-by":"publisher","DOI":"10.3390\/medicines8010003","volume":"8","author":"C Thomas","year":"2021","unstructured":"Thomas C, Konstantinidis C. Neurogenic erectile dysfunction. Where do we stand? Medicines (Basel). 2021;8(1):3. https:\/\/doi.org\/10.3390\/medicines8010003.","journal-title":"Medicines (Basel)"},{"issue":"6","key":"764_CR125","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.toxicon.2009.06.006","volume":"54","author":"FE Villanova","year":"2009","unstructured":"Villanova FE, Andrade E, Leal E, Andrade PM, Borra RC, Troncone LR, et al. Erection induced by Tx2-6 toxin of Phoneutria nigriventer spider: expression profile of genes in the nitric oxide pathway of penile tissue of mice. Toxicon. 2009;54(6):793\u2013801. https:\/\/doi.org\/10.1016\/j.toxicon.2009.06.006.","journal-title":"Toxicon"},{"key":"764_CR126","doi-asserted-by":"publisher","DOI":"10.3389\/fddsv.2023.1201419","volume":"3","author":"N Singh","year":"2023","unstructured":"Singh N, Vayer P, Tanwar S, Poyet J-L, Tsaioun K, Villoutreix BO. Drug discovery and development: introduction to the general public and patient groups. Front Drug Discov. 2023;3:1201419. https:\/\/doi.org\/10.3389\/fddsv.2023.1201419.","journal-title":"Front Drug Discov"},{"key":"764_CR127","doi-asserted-by":"publisher","DOI":"10.3389\/frchs.2024.1490313","volume":"3","author":"Y Wang","year":"2024","unstructured":"Wang Y, Guo S, Jee KF, Herzig V. Thou shalt not pass\u2014arachnid venom peptides interacting with biological membranes. Front Arachn Sci. 2024;3:1490313. https:\/\/doi.org\/10.3389\/frchs.2024.1490313.","journal-title":"Front Arachn Sci"},{"issue":"2","key":"764_CR128","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00401-002-0623-8","volume":"105","author":"L de Paula Le Sueur","year":"2003","unstructured":"de Paula Le Sueur L, Kalapothakis E, da Cruz-H\u00f6fling MA. Breakdown of the blood\u2013brain barrier and neuropathological changes induced by Phoneutria nigriventer spider venom. Acta Neuropathol. 2003;105(2):125\u201334. https:\/\/doi.org\/10.1007\/s00401-002-0623-8.","journal-title":"Acta Neuropathol"},{"issue":"2","key":"764_CR129","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2174\/1389201020666190621104624","volume":"21","author":"AP Dos Santos","year":"2020","unstructured":"Dos Santos AP, de Ara\u00fajo TG, R\u00e1dis-Baptista G. Nanoparticles functionalized with venom-derived peptides and toxins for pharmaceutical applications. Curr Pharm Biotechnol. 2020;21(2):97\u2013109. https:\/\/doi.org\/10.2174\/1389201020666190621104624.","journal-title":"Curr Pharm Biotechnol"},{"issue":"12","key":"764_CR130","doi-asserted-by":"publisher","first-page":"3168","DOI":"10.7150\/thno.19780","volume":"7","author":"H Tan","year":"2017","unstructured":"Tan H, Huang Y, Xu J, Chen B, Zhang P, Ye Z, et al. Spider toxin peptide Lycosin-I functionalized gold nanoparticles for in vivo tumor targeting and therapy. Theranostics. 2017;7(12):3168\u201378. https:\/\/doi.org\/10.7150\/thno.19780.","journal-title":"Theranostics"},{"issue":"10","key":"764_CR131","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2023.103714","volume":"28","author":"AS De Groot","year":"2023","unstructured":"De Groot AS, Roberts BJ, Mattei A, Lelias S, Boyle C, Martin WD. Immunogenicity risk assessment of synthetic peptide drugs and their impurities. Drug Discov Today. 2023;28(10):103714. https:\/\/doi.org\/10.1016\/j.drudis.2023.103714.","journal-title":"Drug Discov Today"},{"issue":"D1","key":"764_CR132","doi-asserted-by":"publisher","first-page":"D436","DOI":"10.1093\/nar\/gkae1092","volume":"53","author":"R Vita","year":"2025","unstructured":"Vita R, Blazeska N, Marrama D, IEDB Curation Team Members, Duesing S, Bennett J, et al. The immune epitope database (IEDB): 2024 update. Nucleic Acids Res. 2025;53(D1):D436\u201343. https:\/\/doi.org\/10.1093\/nar\/gkae1092.","journal-title":"Nucleic Acids Res"},{"issue":"1\u20132","key":"764_CR133","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.ijpharm.2016.12.051","volume":"518","author":"LC Wu","year":"2017","unstructured":"Wu LC, Chen F, Lee SL, Raw A, Yu LX. Building parity between brand and generic peptide products: regulatory and scientific considerations for quality of synthetic peptides. Int J Pharm. 2017;518(1\u20132):320\u201334. https:\/\/doi.org\/10.1016\/j.ijpharm.2016.12.051.","journal-title":"Int J Pharm"},{"key":"764_CR134","doi-asserted-by":"publisher","DOI":"10.1186\/1476-069X-7-50","volume":"7","author":"M Bj\u00f8rling-Poulsen","year":"2008","unstructured":"Bj\u00f8rling-Poulsen M, Andersen HR, Grandjean P. Potential developmental neurotoxicity of pesticides used in Europe. Environ Health. 2008;7:50. https:\/\/doi.org\/10.1186\/1476-069X-7-50.","journal-title":"Environ Health"},{"issue":"3","key":"764_CR135","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/jemt.10024","volume":"56","author":"U Homberg","year":"2002","unstructured":"Homberg U. Neurotransmitters and neuropeptides in the brain of the locust. Microsc Res Tech. 2002;56(3):189\u2013209. https:\/\/doi.org\/10.1002\/jemt.10024.","journal-title":"Microsc Res Tech"},{"issue":"14","key":"764_CR136","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25147529","volume":"25","author":"Y Tian","year":"2024","unstructured":"Tian Y. The role of dopamine neurotransmitters in neurological diseases: new sight. Int J Mol Sci. 2024;25(14):7529. https:\/\/doi.org\/10.3390\/ijms25147529.","journal-title":"Int J Mol Sci"},{"issue":"33","key":"764_CR137","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.2174\/0113816128309913240704095334","volume":"30","author":"AS Patil","year":"2024","unstructured":"Patil AS, Koul S. Role of biosynthesis and catabolism of neurotransmitters in drug discovery for anxiety and depression. Curr Pharm Des. 2024;30(33):2587\u201396. https:\/\/doi.org\/10.2174\/0113816128309913240704095334.","journal-title":"Curr Pharm Des"},{"key":"764_CR138","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1146\/annurev.ento.44.1.429","volume":"44","author":"E Zlotkin","year":"1999","unstructured":"Zlotkin E. The insect voltage-gated sodium channel as target of insecticides. Annu Rev Entomol. 1999;44:429\u201355. https:\/\/doi.org\/10.1146\/annurev.ento.44.1.429.","journal-title":"Annu Rev Entomol"},{"issue":"12","key":"764_CR139","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.3390\/toxins2122851","volume":"2","author":"NJ Saez","year":"2010","unstructured":"Saez NJ, Senff S, Jensen JE, Er SY, Herzig V, Rash LD, et al. Spider-venom peptides as therapeutics. Toxins (Basel). 2010;2(12):2851\u201371. https:\/\/doi.org\/10.3390\/toxins2122851.","journal-title":"Toxins (Basel)"},{"issue":"9","key":"764_CR140","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/psc.2439","volume":"18","author":"A Machado","year":"2012","unstructured":"Machado A, F\u00e1zio MA, Miranda A, Daffre S, Machini MT. Synthesis and properties of cyclic gomesin and analogues. J Pept Sci. 2012;18(9):588\u201398. https:\/\/doi.org\/10.1002\/psc.2439.","journal-title":"J Pept Sci"},{"issue":"4","key":"764_CR141","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1158\/1535-7163.499.3.4","volume":"3","author":"S Swenson","year":"2004","unstructured":"Swenson S, Costa F, Minea R, Sherwin RP, Ernst W, Fujii G, et al. Intravenous liposomal delivery of the snake venom disintegrin contortrostatin limits breast cancer progression. Mol Cancer Ther. 2004;3(4):499\u2013511. https:\/\/doi.org\/10.1158\/1535-7163.499.3.4.","journal-title":"Mol Cancer Ther"},{"key":"764_CR142","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxcx.2020.100038","volume":"6","author":"SA Camperi","year":"2020","unstructured":"Camperi SA, Acosta G, Barredo GR, Iglesias-Garc\u00eda LC, Alves da Silva Caldeira C, Mart\u00ednez-Ceron MC, et al. Synthetic peptides to produce antivenoms against the Cys-rich toxins of arachnids. Toxicon X. 2020;6:100038. https:\/\/doi.org\/10.1016\/j.toxcx.2020.100038.","journal-title":"Toxicon X."},{"issue":"7","key":"764_CR143","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.toxicon.2004.07.012","volume":"44","author":"PH da Silva","year":"2004","unstructured":"da Silva PH, da Silveira RB, Appel MH, Mangili OC, Gremski W, Veiga SS. Brown spiders and loxoscelism. Toxicon. 2004;44(7):693\u2013709. https:\/\/doi.org\/10.1016\/j.toxicon.2004.07.012.","journal-title":"Toxicon"},{"key":"764_CR144","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2022.110809","volume":"161","author":"M Okada","year":"2022","unstructured":"Okada M, Ortiz E. Therapeutic potential of viral vectors that express venom peptides for neurological diseases. Med Hypotheses. 2022;161:110809. https:\/\/doi.org\/10.1016\/j.mehy.2022.110809.","journal-title":"Med Hypotheses"},{"key":"764_CR145","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.01132","volume":"11","author":"KCF Bordon","year":"2020","unstructured":"Bordon KCF, Cologna CT, Fornari-Baldo EC, Pinheiro-J\u00fanior EL, Cerni FA, Amorim FG, et al. From animal poisons and venoms to medicines: achievements, challenges and perspectives in drug discovery. Front Pharmacol. 2020;11:1132. https:\/\/doi.org\/10.3389\/fphar.2020.01132.","journal-title":"Front Pharmacol"},{"issue":"1","key":"764_CR146","doi-asserted-by":"publisher","DOI":"10.1186\/s43094-022-00415-7","volume":"8","author":"AV Joglekar","year":"2022","unstructured":"Joglekar AV, Dehari D, Anjum MM, Dulla N, Chaudhuri A, Singh S, et al. Therapeutic potential of venom peptides: insights in the nanoparticle-mediated venom formulations. Future J Pharm Sci. 2022;8(1):34. https:\/\/doi.org\/10.1186\/s43094-022-00415-7.","journal-title":"Future J Pharm Sci"},{"issue":"8","key":"764_CR147","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/nchem.2779","volume":"9","author":"M Akishiba","year":"2017","unstructured":"Akishiba M, Takeuchi T, Kawaguchi Y, Sakamoto K, Yu H-H, Nakase I, et al. Cytosolic antibody delivery by lipid-sensitive endosomolytic peptide. Nat Chem. 2017;9(8):751\u201361. https:\/\/doi.org\/10.1038\/nchem.2779.","journal-title":"Nat Chem"},{"issue":"15","key":"764_CR148","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.4155\/fmc.14.103","volume":"6","author":"SS Pineda","year":"2014","unstructured":"Pineda SS, Undheim EA, Rupasinghe DB, Ikonomopoulou MP, King GF. Spider venomics: implications for drug discovery. Future Med Chem. 2014;6(15):1699\u2013714. https:\/\/doi.org\/10.4155\/fmc.14.103.","journal-title":"Future Med Chem"},{"key":"764_CR149","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2023.1166601","volume":"11","author":"T L\u00fcddecke","year":"2023","unstructured":"L\u00fcddecke T, Paas A, Harris RJ, Talmann L, Kirchhoff KN, Billion A, et al. Venom biotechnology: casting light on nature\u2019s deadliest weapons using synthetic biology. Front Bioeng Biotechnol. 2023;11:1166601. https:\/\/doi.org\/10.3389\/fbioe.2023.1166601.","journal-title":"Front Bioeng Biotechnol"},{"key":"764_CR150","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2024.1465459","volume":"12","author":"L Freuville","year":"2024","unstructured":"Freuville L, Matthys C, Quinton L, Gillet JP. Venom-derived peptides for breaking through the glass ceiling of drug development. Front Chem. 2024;12:1465459. https:\/\/doi.org\/10.3389\/fchem.2024.1465459.","journal-title":"Front Chem"},{"key":"764_CR151","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/bs.mie.2021.01.029","volume":"654","author":"C Saikia","year":"2021","unstructured":"Saikia C, Ben-Nissan G, Reuveny E, Karbat I. Production of recombinant venom peptides as tools for ion channel research. Methods Enzymol. 2021;654:169\u2013201. https:\/\/doi.org\/10.1016\/bs.mie.2021.01.029.","journal-title":"Methods Enzymol"},{"issue":"1","key":"764_CR152","doi-asserted-by":"publisher","DOI":"10.1186\/s40409-015-0018-7","volume":"21","author":"H Clement","year":"2015","unstructured":"Clement H, Flores V, Diego-Garcia E, Corrales-Garcia L, Villegas E, Corzo G. A comparison between the recombinant expression and chemical synthesis of a short cysteine-rich insecticidal spider peptide. J Venom Anim Toxins Incl Trop Dis. 2015;21(1):19. https:\/\/doi.org\/10.1186\/s40409-015-0018-7.","journal-title":"J Venom Anim Toxins Incl Trop Dis"},{"issue":"6","key":"764_CR153","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0021608","volume":"6","author":"E Meng","year":"2011","unstructured":"Meng E, Cai TF, Li WY, Zhang H, Liu YB, Peng K, et al. Functional expression of spider neurotoxic peptide huwentoxin-I in E. coli. PLoS ONE. 2011;6(6):e21608. https:\/\/doi.org\/10.1371\/journal.pone.0021608.","journal-title":"PLoS ONE"},{"key":"764_CR154","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1039\/9781849737876-00275","volume-title":"Venoms to drugs: venom as a source for the development of human therapeutics","author":"M Akcan","year":"2015","unstructured":"Akcan M, Craik DJ. Engineering venom peptides to improve their stability and bioavailability. In: King GF, editor. Venoms to drugs: venom as a source for the development of human therapeutics. Cambridge: Royal Society of Chemistry; 2015. p. 275\u201389. https:\/\/doi.org\/10.1039\/9781849737876-00275."},{"issue":"5","key":"764_CR155","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s44222-024-00152-x","volume":"2","author":"F Wan","year":"2024","unstructured":"Wan F, Wong F, Collins JJ, de la Fuente-Nunez C. Machine learning for antimicrobial peptide identification and design. Nat Rev Bioeng. 2024;2(5):392\u2013407. https:\/\/doi.org\/10.1038\/s44222-024-00152-x.","journal-title":"Nat Rev Bioeng"},{"issue":"5","key":"764_CR156","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10462-025-11148-3","volume":"58","author":"KR Rezaee","year":"2025","unstructured":"Rezaee KR, Eslami H. Bridging machine learning and peptide design for cancer treatment: a comprehensive review. Artif Intell Rev. 2025;58(5):1\u201359. https:\/\/doi.org\/10.1007\/s10462-025-11148-3.","journal-title":"Artif Intell Rev"},{"issue":"5","key":"764_CR157","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41573-019-0013-8","volume":"18","author":"H Wulff","year":"2019","unstructured":"Wulff H, Christophersen P, Colussi P, Chandy KG, Yarov-Yarovoy V. Antibodies and venom peptides: new modalities for ion channels. Nat Rev Drug Discov. 2019;18(5):339\u201357. https:\/\/doi.org\/10.1038\/s41573-019-0013-8.","journal-title":"Nat Rev Drug Discov"},{"issue":"24","key":"764_CR158","doi-asserted-by":"publisher","first-page":"4771","DOI":"10.1039\/d5sm00396b","volume":"21","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Gao J, Yuan L, Duan B, Yang H, Ma L, et al. Self-assembling peptide hydrogels: design, mechanisms, characterization, and biomedical applications. Soft Matter. 2025;21(24):4771\u201391. https:\/\/doi.org\/10.1039\/d5sm00396b.","journal-title":"Soft Matter"},{"issue":"4","key":"764_CR159","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s11030-006-9050-4","volume":"10","author":"P Escoubas","year":"2006","unstructured":"Escoubas P. Molecular diversification in spider venoms: a web of combinatorial peptide libraries. Mol Divers. 2006;10(4):545\u201354. https:\/\/doi.org\/10.1007\/s11030-006-9050-4.","journal-title":"Mol Divers"},{"issue":"6","key":"764_CR160","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1111\/brv.13120","volume":"99","author":"O Mich\u00e1lek","year":"2024","unstructured":"Mich\u00e1lek O, King GF, Pek\u00e1r S. Prey specificity of predatory venoms. Biol Rev Camb Philos Soc. 2024;99(6):2253\u201373. https:\/\/doi.org\/10.1111\/brv.13120.","journal-title":"Biol Rev Camb Philos Soc"},{"issue":"1","key":"764_CR161","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29010035","volume":"29","author":"R Guo","year":"2023","unstructured":"Guo R, Guo G, Wang A, Xu G, Lai R, Jin H. Spider-venom peptides: structure, bioactivity, strategy, and research applications. Molecules. 2023;29(1):35. https:\/\/doi.org\/10.3390\/molecules29010035.","journal-title":"Molecules"}],"container-title":["BioDrugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40259-025-00764-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40259-025-00764-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40259-025-00764-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T06:01:44Z","timestamp":1774418504000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40259-025-00764-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":161,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["764"],"URL":"https:\/\/doi.org\/10.1007\/s40259-025-00764-8","relation":{},"ISSN":["1173-8804","1179-190X"],"issn-type":[{"value":"1173-8804","type":"print"},{"value":"1179-190X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,13]]},"assertion":[{"value":"28 December 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there is no conflict of interest regarding the publication of this paper. The authors have no financial, personal, or professional relationships that could inappropriately influence or bias the content of this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"J.L.B., E.A.A., J.G.J., R.A.C., and C.N.N. conducted comprehensive literature review and contributed to the writing of the manuscript. M.K.D. co-conceptualized the review. S.M.L. led the overall conceptualization and provided critical input and editorial oversight. L.A.G. contributed technical expertise and guidance throughout the development of the manuscript. All authors have read and approved the final version of the manuscript and agree to be accountable for the work.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}